clinical trial · NCT05278676
A Single and Multiple Dose Study of Dotinurad in Chinese Healthy Participants
Eisai Co., Ltd.·phase1·completed·n = 26
Healthy VolunteersDotinurad
brief summary
The primary purpose of this study is to evaluate the pharmacokinetics (PK) of dotinurad following single and multiple oral doses of dotinurad in Chinese healthy male and female participants.
started
Jul 1, 2022
primary completion
Dec 13, 2022
completion
Dec 13, 2022
last updated
Sep 14, 2023
official title
A Single and Multiple Dose Pharmacokinetic Study of Dotinurad in Chinese Healthy Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol